SourcesWeb search

Products 11 to 20 of 130

Avant Meats by Avant Meats
Biotech components: N/A
Business models: B2C
Country of production: N/A
Country of distribution: N/A
Intended consumer: N/A
Date added: 2019/07/02 11:19 (5 years ago)
Date last modified: 2019/07/02 11:19 (5 years ago)
Known funding amount: N/A
Funding types: N/A
Industry: Food & Agriculture
Market status: Early Stage Concept + More information needed
Organization type(s): Private Company
Product categories: Food
Production process: Open Release
Source: Web search
Trading symbol: N/A
Value chain stage: Finished Product
Bacterial Cellulose produced by Microorganisms by Chinese Academy of Sciences
Biotech components: Bacteria + Enzyme + Microbe
Business models: B2B
Country of production: N/A
Country of distribution: N/A
Intended consumer: N/A
Date added: 2020/02/10 09:55 (4 years ago)
Date last modified: 2020/02/10 09:55 (4 years ago)
Known funding amount: N/A
Funding types: Government + Research Institution + University
Industry: Industrial + Medical + Science
Market status: Early Stage Concept
Organization type(s): Research Institution + University
Product categories: N/A
Production process: N/A
Source: Web search
Trading symbol: N/A
Value chain stage: Platform
Bacterial toxin promoting tissue healing by Friedrich Schiller University Jena
Biotech components: Bacteria
Business models: B2B + B2C
Country of production: N/A
Country of distribution: N/A
Intended consumer: N/A
Date added: 2020/12/18 14:39 (3 years ago)
Date last modified: 2020/12/18 14:39 (3 years ago)
Known funding amount: N/A
Funding types: University
Industry: Medical
Market status: Early Stage Concept
Organization type(s): University
Product categories: Medical Treatment + Medicine
Production process: N/A
Source: Web search
Trading symbol: N/A
Value chain stage: N/A
Balletic Foods Clean Meat by Balletic Foods
Biotech components: N/A
Business models: B2C
Country of production: N/A
Country of distribution: N/A
Intended consumer: N/A
Date added: 2019/07/02 11:19 (5 years ago)
Date last modified: 2019/07/02 11:19 (5 years ago)
Known funding amount: N/A
Funding types: Private Funding
Industry: Food & Agriculture
Market status: Under Development + More information needed
Organization type(s): Private Company
Product categories: Food
Production process: Open Release
Source: Web search
Trading symbol: N/A
Value chain stage: Finished Product
Biotech components: Animal
Business models: B2C
Country of production: N/A
Country of distribution: N/A
Intended consumer: N/A
Date added: 2019/07/02 11:19 (5 years ago)
Date last modified: 2019/07/02 11:19 (5 years ago)
Known funding amount: N/A
Funding types: N/A
Industry: Food & Agriculture
Market status: Early Stage Concept + More information needed
Organization type(s): Private Company
Product categories: Food
Production process: Open Release
Source: Web search
Trading symbol: N/A
Value chain stage: Finished Product
Bio-DEMâ„¢ by Lygos, Inc (Advanced Biofuels Process Demonstration Unit)
Biotech components: Enzyme + Gene Editing + Microbe + Plant
Business models: B2B
Country of production: N/A
Country of distribution: N/A
Intended consumer: N/A
Date added: 2019/09/12 14:33 (4 years ago)
Date last modified: 2019/09/12 14:33 (4 years ago)
Known funding amount: N/A
Funding types: Shareholder Investment + Venture Capital
Industry: Industrial + Multipurpose
Market status: On the market
Organization type(s): Private Company
Product categories: Additive + Chemical
Production process: N/A
Source: Web search
Trading symbol: N/A
Value chain stage: Input
bioCement by bioMason
Biotech components: Bacteria
Business models: B2B + B2C
Country of production: USA
Country of distribution: USA
Intended consumer: Commercial + Government
Date added: 2018/08/30 11:49 (5 years ago)
Date last modified: 2018/10/08 14:47 (5 years ago)
Known funding amount: 2,800,000 USD
Funding types: Foundation + Government + University + Venture Capital
Industry: Industrial
Market status: Under Development
Organization type(s): Private Company
Product categories: Construction
Production process: Closed Production
Source: Web search
Trading symbol: N/A
Value chain stage: Finished Product
Bioengineered mRNA for gene therapy by University of Wisconin-Madison
Biotech components: Gene Editing
Business models: B2B
Country of production: N/A
Country of distribution: N/A
Intended consumer: N/A
Date added: 2020/12/18 14:36 (3 years ago)
Date last modified: 2020/12/18 14:36 (3 years ago)
Known funding amount: N/A
Funding types: University
Industry: Medical
Market status: Early Stage Concept
Organization type(s): University
Product categories: N/A
Production process: N/A
Source: Web search
Trading symbol: N/A
Value chain stage: Platform
Biotech components: Enzyme + Plant
Business models: B2B
Country of production: N/A
Country of distribution: N/A
Intended consumer: N/A
Date added: 2020/12/18 14:38 (3 years ago)
Date last modified: 2020/12/18 14:38 (3 years ago)
Known funding amount: N/A
Funding types: University
Industry: Food & Agriculture
Market status: Early Stage Concept
Organization type(s): University
Product categories: Plant
Production process: N/A
Source: Web search
Trading symbol: N/A
Value chain stage: Finished Product
Biotech components: Microbe
Business models: B2B
Country of production: N/A
Country of distribution: N/A
Intended consumer: N/A
Date added: 2019/09/12 15:18 (4 years ago)
Date last modified: 2019/09/12 15:18 (4 years ago)
Known funding amount: N/A
Funding types: N/A
Industry: Medical
Market status: On the market
Organization type(s): Private Company
Product categories: Medical Treatment + Medicine
Production process: Open Release
Source: Web search
Trading symbol: N/A
Value chain stage: Finished Product